Form 8-K - Current report:
SEC Accession No. 0001558370-24-016391
Filing Date
2024-12-19
Accepted
2024-12-19 16:30:09
Documents
15
Period of Report
2024-12-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpth-20241219x8k.htm   iXBRL 8-K 40116
2 EX-99.1 bpth-20241219xex99d1.htm EX-99.1 18480
3 GRAPHIC bpth-20241219xex99d1001.jpg GRAPHIC 10795
  Complete submission text file 0001558370-24-016391.txt   198870

Data Files

Seq Description Document Type Size
4 EX-101.SCH bpth-20241219.xsd EX-101.SCH 3290
5 EX-101.LAB bpth-20241219_lab.xml EX-101.LAB 15928
6 EX-101.PRE bpth-20241219_pre.xml EX-101.PRE 10128
17 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20241219x8k_htm.xml XML 4915
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS, INC. (Filer) CIK: 0001133818 (see all company filings)

EIN.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 241563731
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)